Diffuse large B-cell lymphoma on the back of a patient with AIDS:: Successful treatment by the CD20 monoclonal antibody rituximab

被引：1
|
作者：
Voigtländer, C
Harrer, T
Schneider, L
Schulze-Koops, H
Niedobitek, G
Lüftl, M
机构：
[1] Univ Hosp Erlangen, Dept Dermatol, D-91052 Erlangen, Germany
[2] Univ Hosp Erlangen, Dept Med 3, Erlangen, Germany
[3] Univ Erlangen Nurnberg, Inst Pathol, Erlangen, Germany
来源：
INTERNATIONAL JOURNAL OF DERMATOLOGY | 2005年 / 44卷 / 11期
关键词：
D O I：
10.1111/j.1365-4632.2005.02649.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：976 / 978
页数：4
相关论文
共 50 条
  • [1] Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti- CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group
    Wada, Naoki
    Kohara, Masaharu
    Ogawa, Hiroyasu
    Sugiyama, Haruo
    Fukuhara, Shirou
    Tatsumi, Yoichi
    Kanamaru, Akihisa
    Hino, Masayuki
    Kanakura, Yuzuru
    Morii, Eiichi
    Aozasa, Katsuyuki
    CASE REPORTS IN ONCOLOGY, 2009, 2 (03): : 194 - 201
  • [2] Successful treatment of primary cardiac lymphoma with monoclonal CD20 antibody (rituximab)
    Nakagawa, Y
    Ikeda, U
    Hirose, M
    Ubukata, S
    Katsuki, T
    Kaminishi, Y
    Saito, T
    Hironaka, M
    Izumi, T
    Shimada, K
    CIRCULATION JOURNAL, 2004, 68 (02) : 172 - 173
  • [3] Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab
    Takashi Sonoki
    Yaqiong Li
    Setsuko Miyanishi
    Hirokazu Nakamine
    Nobuyoshi Hanaoka
    Hiroshi Matsuoka
    Ichiro Mori
    Hideki Nakakuma
    International Journal of Hematology, 2009, 89 : 400 - 402
  • [4] Establishment of a novel CD20 negative mature B-cell line, WILL2, from a CD20 positive diffuse large B-cell lymphoma patient treated with rituximab
    Sonoki, Takashi
    Li, Yaqiong
    Miyanishi, Setsuko
    Nakamine, Hirokazu
    Hanaoka, Nobuyoshi
    Matsuoka, Hiroshi
    Mori, Ichiro
    Nakakuma, Hideki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (03) : 400 - 402
  • [5] Successful Treatment of Diffuse Large B-Cell Lymphoma in a Patient With Ataxia Telangiectasia Using Rituximab
    Machida, Shizuka
    Tomizawa, Daisuke
    Tamaichi, Hiroyuki
    Okawa, Teppei
    Endo, Akifumi
    Imai, Kohsuke
    Nagasawa, Masayuki
    Morio, Tomohiro
    Mizutani, Shuki
    Takagi, Masatoshi
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2013, 35 (06) : 482 - 485
  • [6] Primary cutaneous large B-cell lymphoma of the legs - A distinct clinical pathologic entity treated with CD20 monoclonal antibody (Rituximab)
    Aboulafia, DM
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (03): : 237 - 240
  • [7] Case report of primary CD20 negative diffuse large B-cell lymphoma
    Devi, Kanti
    Ali, Natashi
    Ahmed, Arsalan
    OXFORD MEDICAL CASE REPORTS, 2021, (11-12): : 447 - 449
  • [8] Diffuse large B-cell lymphoma, leg type with loss of CD20 expression
    Thomas, A.
    Cibull, T.
    O'Malley, D.
    Billings, S.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2007, 34 (01) : 116 - 116
  • [9] Experimental treatment of human diffuse large B-cell lymphoma xenografts by doxycycline alone or in combination with the anti-CD20 chimeric monoclonal antibody rituximab
    Assayag, Franck
    Brousse, Nicole
    Couturier, Jerome
    Macintyre, Elizabeth
    Mathiot, Claire
    Dewulf, Sebastien
    Froget, Benoit
    Vincent-Salomon, Anne
    Decaudin, Didier
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (06) : 387 - 388
  • [10] Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
    Papageorgiou, Sotirios G.
    Thomopoulos, Thomas P.
    Liaskas, Athanasios
    Vassilakopoulos, Theodoros P.
    CANCERS, 2022, 14 (08)
12345